Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3578070)

Published in J Bone Miner Res on March 01, 2013

Authors

Anne Tsampalieros1, Pooja Gupta, Michelle R Denburg, Justine Shults, Babette S Zemel, Sogol Mostoufi-Moab, Rachel J Wetzsteon, Rita M Herskovitz, Krista M Whitehead, Mary B Leonard

Author Affiliations

1: Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.

Associated clinical trials:

The Effect of Exercise on Muscle Dysfunction in Cystinosis | NCT04071548

Articles citing this

Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care (2015) 1.72

Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2013) 1.06

Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab (2013) 0.92

Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab (2013) 0.91

Crohn's disease and growth deficiency in children and adolescents. World J Gastroenterol (2014) 0.88

Muscle torque relative to cross-sectional area and the functional muscle-bone unit in children and adolescents with chronic disease. J Bone Miner Res (2015) 0.85

Pathological fractures in paediatric patients with inflammatory bowel disease. Eur J Pediatr (2013) 0.84

Skeletal outcomes by peripheral quantitative computed tomography and dual-energy X-ray absorptiometry in adolescent girls with anorexia nervosa. Osteoporos Int (2016) 0.84

Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporos Int (2013) 0.83

Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr (2015) 0.77

A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture. Osteoporos Int (2015) 0.77

Changes in DXA and quantitative CT measures of musculoskeletal outcomes following pediatric renal transplantation. Am J Transplant (2013) 0.76

A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. Pharmacogenomics J (2016) 0.75

Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controls. Bone (2013) 0.75

Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review. Ital J Pediatr (2016) 0.75

Low bone mineral density in adolescents with leukemia after hematopoietic stem cell transplantation: prolonged steroid therapy for GvHD and endocrinopathy after hematopoietic stem cell transplantation might be major concerns? Bone Marrow Transplant (2016) 0.75

Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS. Pediatr Nephrol (2014) 0.75

GLUCOCORTICOID-INDUCED BONE DISEASE: MECHANISMS AND IMPORTANCE IN PEDIATRIC PRACTICE. Rev Paul Pediatr (2017) 0.75

Articles cited by this

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29

Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics (2002) 12.32

The LMS method for constructing normalized growth standards. Eur J Clin Nutr (1990) 6.89

Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc (1980) 5.04

Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int (2007) 3.12

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr (1981) 3.01

Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology (2003) 2.84

Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res (2011) 2.55

Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology (2008) 2.21

Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol (1997) 2.18

Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab (2011) 2.16

Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest (2006) 1.92

Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr (2008) 1.83

Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab (2010) 1.66

Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res (2001) 1.62

Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during GH replacement due to early bone remodeling. J Clin Endocrinol Metab (2003) 1.57

Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol (1994) 1.54

Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res (2009) 1.24

The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am (1998) 1.21

Recovery from osteoporosis through skeletal growth: early bone mass acquisition has little effect on adult bone density. FASEB J (2002) 1.20

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol (2011) 1.19

Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res (2001) 1.17

Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med (2010) 1.15

Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res (2011) 1.13

Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Bone (2007) 1.11

Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol (1995) 1.05

pQCT measurement of bone parameters in young children: validation of technique. J Clin Densitom (2000) 1.03

Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr (2004) 1.02

The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr (1991) 1.02

Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int (2011) 1.00

Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease. J Bone Miner Res (2007) 0.98

Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant (2005) 0.97

A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol (1997) 0.95

Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol (2012) 0.93

Use of quasi-least squares to adjust for two levels of correlation. Biometrics (2002) 0.93

Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol (2005) 0.92

Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. Kidney Int (2005) 0.92

Muscle edema. AJR Am J Roentgenol (2010) 0.87

[Evaluation of bone mineral turnover in children with nephrotic syndrome--the implications of original disease and the effects of corticosteroids on bone metabolism]. Nihon Jinzo Gakkai Shi (1993) 0.77

Articles by these authors

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab (2007) 4.00

Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med (2004) 3.87

New intrauterine growth curves based on United States data. Pediatrics (2010) 3.72

Infant weight gain and childhood overweight status in a multicenter, cohort study. Pediatrics (2002) 3.50

A policy-based school intervention to prevent overweight and obesity. Pediatrics (2008) 3.41

Rapid weight gain during infancy and obesity in young adulthood in a cohort of African Americans. Am J Clin Nutr (2003) 3.33

Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ (2013) 3.22

Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder. Br J Psychiatry (2012) 2.83

Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr (2007) 2.73

Cortical bone water: in vivo quantification with ultrashort echo-time MR imaging. Radiology (2008) 2.71

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant (2011) 2.60

Gestational weight gain and risk of overweight in the offspring at age 7 y in a multicenter, multiethnic cohort study. Am J Clin Nutr (2008) 2.58

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry (2010) 2.56

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone (2008) 2.53

Fat and lean BMI reference curves in children and adolescents and their utility in identifying excess adiposity compared with BMI and percentage body fat. Am J Clin Nutr (2013) 2.49

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42

Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab (2010) 2.29

Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology (2008) 2.21

Trial of family and friend support for weight loss in African American adults. Arch Intern Med (2009) 2.10

Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression. Arthritis Rheumatol (2014) 2.06

Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. J Pediatr (2004) 2.06

Obesity during childhood and adolescence augments bone mass and bone dimensions. Am J Clin Nutr (2004) 2.00

Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol (2009) 1.98

Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy. Pediatr Blood Cancer (2013) 1.98

Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr (2002) 1.95

KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis (2010) 1.93

Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr (2008) 1.83

Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76

Proximal femur bone geometry is appropriately adapted to lean mass in overweight children and adolescents. Bone (2005) 1.70

Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab (2010) 1.66

Changes in bone structure and the muscle-bone unit in children with chronic kidney disease. Kidney Int (2012) 1.62

Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology (2013) 1.60

Effect of clobazam as add-on antiepileptic drug in patients with epilepsy. Indian J Med Res (2014) 1.53

Silent infarcts in young children with sickle cell disease. Br J Haematol (2009) 1.51

Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr (2005) 1.49

Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol (2012) 1.48

Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol (2006) 1.45

Management of extra oral sinus cases: a clinical dilemma. J Endod (2004) 1.45

Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42

Risk Factors for Extubation Failure Following Neonatal Cardiac Surgery. Pediatr Crit Care Med (2015) 1.41

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom (2008) 1.41

Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma. J Immunol (2008) 1.32

Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2011) 1.29

Feeding patterns of full-term and preterm infants at forty weeks postconceptional age. J Dev Behav Pediatr (2002) 1.29

Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol (2010) 1.27

Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26

Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography. Bone (2004) 1.26

Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology (2010) 1.26

The relationship between relative weight and school attendance among elementary schoolchildren. Obesity (Silver Spring) (2007) 1.26

Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res (2009) 1.24

Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res (2008) 1.24

Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr (2005) 1.24

Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis (2007) 1.23

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab (2003) 1.23

Variation in inpatient therapy and diagnostic evaluation of children with Henoch Schönlein purpura. J Pediatr (2009) 1.20

Current concepts in pediatric bone disease. Pediatr Clin North Am (2002) 1.20

H2A.Z and H3.3 histone variants affect nucleosome structure: biochemical and biophysical studies. Biochemistry (2009) 1.19

Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res (2004) 1.17

Body composition in children with sickle cell disease. Am J Clin Nutr (2002) 1.17

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology (2012) 1.16

Physical performance and frailty in chronic kidney disease. Am J Nephrol (2013) 1.16